180 Life Sciences Corp. received a letter on March 13, 2024 from The Nasdaq Stock Market indicating that the Company has regained full compliance with the minimum bid price for continued listing on the Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2). As indicated in the letter, Nasdaq determined that for 10 consecutive business days, the closing bid price of the Company’s common stock was at or above $1.00 per share. Accordingly, the Company has regained compliance with the Minimum Bid Price Requirement.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ATNF:
- 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
- 180 Life Sciences Board Reshuffle and Strategic Refocus
- 180 Life Sciences Appoints Blair Jordan as Board Director
- 180 Life Sciences trading halted, news pending
- 180 Life Sciences announces 1-for-19 reverse stock split
